Trial Profile
Angiographic and clinical outcomes of everolimus-eluting and zotarolimus-eluting stent implantation in patients with multivessel coronary artery disease
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 27 Oct 2015
Price :
$35
*
At a glance
- Drugs Everolimus (Primary) ; Zotarolimus (Primary)
- Indications Coronary artery disease; Coronary artery restenosis
- Focus Adverse reactions; Therapeutic Use
- 27 Oct 2015 New trial record
- 02 Sep 2015 Results presented at the ESC Congress 2015: Annual Congress of the European Society of Cardiology.